[The immunomodulating action of interferon preparations. The effect of medicinal alpha-interferon preparations on the rosette-forming activity of human blood lymphocytes]. 1990

Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn

Effects of alpha-interferon (alpha-IF) medical preparations on human blood lymphocyte rosette-forming activity was under study. Blood samples from 40 donors and 81 patients with chronic pyoderma, lupus erythematosus, and pemphigus were examined. Interferon preparations alpha-IF for nasal administration and IN-1 and IN-2 (or leukinterferon) for injections were used. The results evidence that IF preparations activities depend on the methods of the preparation synthesis and purification. alpha-IF and leukinterferon most effectively enhanced the lymphocyte ability to spontaneous, early, and active rosette formation. IN-1 was found less active and enhanced only the ability to spontaneous E-rosette formation, but had no effect on early active E-RFC subpopulations. IF preparations elevated the counts of E-RFC anf active RFC only if these levels were lowered; if these values were normal the agents had no effect.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D011711 Pyoderma Any purulent skin disease (Dorland, 27th ed). Pyodermas
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations

Related Publications

Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
August 1988, Gematologiia i transfuziologiia,
Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
April 1980, Immunopharmacology,
Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
April 1974, International journal of cancer,
Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
January 1994, Vestnik otorinolaringologii,
Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
March 1980, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
December 1978, Journal of immunology (Baltimore, Md. : 1950),
Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
May 1977, Blut,
Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
January 1980, Nouvelle revue francaise d'hematologie,
Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
October 1980, Prostaglandins and medicine,
Zh I Avdeeva, and N M Mazina, and T V Lukasheva, and O R Krylov, and V P Kuznetsov, and N V Medunitsyn
July 1980, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Copied contents to your clipboard!